Latest Insights in Awards

Llusern bags a hat-trick at ICS 2026.
Llusern is pleased to announce that three abstracts will be presented at the International Continence Society congress in Maastricht, 6-9…

Longitude Prize on AMR
And winner is… It was a case of so very near and yet so far for Llusern Scientific at the…

Llusern win at MediWales Awards 2022
Emma and Jeroen accept the Partnership with the NHS Award Last Thursday we were thrilled to win the ‘Partnership with…

Llusern wins at the Wales STEM Awards
CSO Jeroen Nieuwland (back row, fourth from the right) with the Innovation Award Llusern Scientific were delighted to be the…

CEO awarded top prize to develop UTI test
Llusern Scientific CEO and co-founder, Dr Emma Hayhurst, has been awarded the Innovation Prize from ‘Women in Innovation’. With nearly…
Start a conversation with Llusern
Llusern is developing treatment-directing diagnostics for high-volume healthcare challenges, starting with rapid molecular UTI testing. To learn more about the company, the product and the opportunity ahead, speak to the Llusern team.